Celltrion.
South Korean biopharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 25
What's happening
Earlier this month
-
Celltrion's stock rose and Hanwha Aerospace's stock fell on October 1, 2026, driven by market sentiment.Some support1 report
-
Celltrion hosted a symposium in Barcelona on October 1, 2026, featuring experts from King's College London.Some support2 reports
-
Celltrion presented data at the American College of Gastroenterology meeting in New York.Some support2 reports
Gone quiet
No new reports in 90+ days-
A drug has received FDA approval for treatment, and a collaboration is providing drug monitoring services.Some support4 reports
-
Amgen, Pfizer, and Celltrion are key players poised for rapid expansion in the biosimilars market in the US.Some support1 report1 development inside
-
President Lee Jae Myung praised Celltrion for its investment pledge on July 1.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Celltrion this week
News at the entities that move Celltrion most-
FDA StructuralThe FDA approved Miplyffa for the treatment of Niemann-Pick disease.Moves Celltrion
-
Amgen OperationalMorgan Stanley and Citigroup raised price objectives on Amgen shares, with MarketBeat reporting the consensus rating.Moves Celltrion
-
Abraham StructuralLocal political updates include a Coronado mayor facing a council race, Abraham running in San Diego, and Jennifer Campbell being termed out of council.Moves Celltrion
-
King's College London OperationalExpert comments were made regarding military manpower issues involving the British Army.Moves Celltrion
-
Lee Jae Myung OperationalAdministration faces criticism over defense policy failures, with calls for stronger defense capabilities and active diplomacy.Moves Celltrion
-
Middle East Shared contextSappi is facing operational challenges due to the ongoing geopolitical conflict in the Middle East, which is driving up petrochemical costs and market risks.Moves Celltrion
Connections
The 15 strongest of 25, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
The FDA formally regulates and approves Celltrion's drug products.
-
PROMETHEUS Operational
The two entities maintain an active operational partnership, exchanging specialized drug monitoring and TDM services.
-
Amgen Operational
Celltrion and Amgen are active competitors within the biosimilars market and share the life sciences hub context.
-
ANSER Structural
Celltrion functions as a critical supplier, providing necessary components and support for ANSER's IFX testing program.
-
Abraham Structural
Abraham is associated with Celltrion, providing commentary on its programs, consistent with an advisory or employment role.
-
King's College London Operational
Celltrion hosts a symposium featuring expertise provided by King's College London.
-
American College of Gastroenterology Mentioned together
Celltrion presented scientific data at a meeting organized by the American College of Gastroenterology.
-
SK Square Operational
The companies are identified as competitors who operate in the same market and are subject to shared market pressures.
Show all 15 connections
-
Middle East Shared context
Celltrion's market sentiment is influenced by geopolitical risks associated with the Middle East region.
-
Lee Jae Myung Operational
Lee Jae Myung publicly praised Celltrion's investment pledge.
-
Barcelona Shared context
Celltrion participated in a conference event held in Barcelona.
-
Korea Shared context
The company operates within the economic and geographic context of South Korea.
-
Samsung Electronics Shared context
Both companies are identified as major South Korean companies affected by a tech slump.
-
Spain Shared context
Celltrion is planning to expand its presence in the European IBD market.
-
Seoul Shared context
Celltrion operates within the geographical context of Seoul.
History
Events by the month they beganOctober 2026
3 events- Celltrion's stock rose and Hanwha Aerospace's stock fell on October 1, 2026, driven by market sentiment.
- Celltrion hosted a symposium in Barcelona on October 1, 2026, featuring experts from King's College London.
- Celltrion presented data at the American College of Gastroenterology meeting in New York.